Best Fertility Centre – Dr. Swapna Naik

Call Now WhatsApp Book Appointment

Category: Blog

If you have endometriosis and have experienced recurrent miscarriage, you’ve probably wondered if the two are connected. The honest answer: research suggests a real association, but it isn’t a fully settled question — and understanding both sides of the evidence helps you have a more informed conversation with your specialist.

What Does Recurrent Miscarriage Mean?

Recurrent pregnancy loss (RPL) is generally defined as two or more pregnancy losses before 20–24 weeks of gestation. It’s worth knowing that even without any endometriosis, roughly half of RPL cases have no clearly identified cause after standard testing — a reminder that this is a genuinely complex area of reproductive medicine.

What Does the Research Say About Endometriosis and Miscarriage?

Evidence Supporting a Connection

A meta-analysis found that women with endometriosis have a statistically significant higher risk of several pregnancy-related complications, including miscarriage, preterm birth, placenta previa, smaller-than-expected babies, and caesarean delivery.

A large Scottish cohort study compared over 5,000 women with surgically confirmed endometriosis to nearly 9,000 women without the condition, and concluded that endometriosis does predispose women to a higher risk of early pregnancy loss and later pregnancy complications.

Separately, a retrospective study of IVF patients found a higher miscarriage rate following fresh embryo transfer specifically in women with endometriosis.

Evidence Questioning the Strength of the Connection

It’s important to present the full picture honestly: a separate systematic review reached a notably different conclusion, finding that pregnancy complications related to endometriosis are actually rare, and that there isn’t strong evidence the condition has a major detrimental effect on pregnancy outcomes overall.

This genuine disagreement in the research reflects how complex and still-evolving this area of study is.

What Mechanisms Might Explain a Connection?

Researchers have proposed several biologically plausible pathways:

  • Chronic inflammation altering endometrial receptivity — a mechanism shared with related conditions like adenomyosis and chronic endometritis, potentially affecting how well the endometrium supports early pregnancy
  • Immune system dysfunction — the endometrium plays a genuinely important role in creating immune tolerance toward the developing embryo, and this process may be disrupted by endometriosis-related inflammation
  • Pelvic inflammatory effects on the oocyte and embryo — specifically relevant to natural conception, where the egg and early embryo develop within the pelvic environment potentially affected by endometriosis inflammation

An Important, Practical Nuance: Natural Conception vs. IVF

This is genuinely useful to understand: some proposed mechanisms — particularly pelvic inflammation affecting oocyte and embryo development — are specific to natural conception, where the egg and early embryo remain within the body’s pelvic environment. With IVF, fertilisation and early embryo development happen outside the body in a controlled lab environment, potentially bypassing this specific pathway, even though other endometrium-related mechanisms could still apply once the embryo is transferred.

This doesn’t mean IVF eliminates all endometriosis-related miscarriage risk, but it’s a meaningful distinction worth discussing with your specialist if you’re weighing natural conception against assisted reproduction.

What Does This Mean for Your Care?

Given that the evidence is genuinely mixed rather than fully conclusive, here’s what’s practically useful:

  • If you have endometriosis and recurrent miscarriage, it’s reasonable to consider endometriosis as one possible contributing factor — but not to assume it’s automatically the sole explanation, especially since roughly half of all RPL cases (with or without endometriosis) remain unexplained even after thorough evaluation
  • A comprehensive RPL work-up remains important regardless of your endometriosis diagnosis — including genetic testing, uterine evaluation, hormonal assessment, and blood clotting disorder screening
  • Treatment for endometriosis itself (hormonal or surgical) is generally aimed at improving fertility and reducing pain, rather than being a proven, specific treatment for preventing miscarriage — this distinction matters when setting expectations

Should Endometriosis Treatment Be Part of Your Miscarriage Prevention Plan?

This is worth discussing directly with your specialist, since the evidence doesn’t currently support a simple “treat the endometriosis and miscarriage risk resolves” narrative. Any treatment decision should weigh your specific symptoms, fertility goals, and overall RPL evaluation findings together — not treat endometriosis in isolation as the answer to recurrent loss.

Endometriosis and Recurrent Miscarriage Care at Sree Swapna Fertility Centre

As one of the best fertility centers in Hyderabad, we approach recurrent miscarriage with a comprehensive evaluation — considering endometriosis as one possible contributing factor among several, rather than assuming it explains everything.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, and is a trained laparoscopic surgeon with over 15 years of experience. Our approach to recurrent pregnancy loss includes thorough genetic, hormonal, and structural evaluation, alongside assessment for endometriosis where relevant — giving you an honest, complete picture rather than a single explanation that may not tell the whole story.

Both our Kondapur and Attapur clinics offer the diagnostic facilities needed for a comprehensive recurrent miscarriage evaluation, whether or not endometriosis is part of your history.

Frequently Asked Questions

1. Does endometriosis increase the risk of miscarriage?

Research is genuinely mixed — some large studies show a statistically higher risk, while at least one systematic review found pregnancy complications from endometriosis to be rare.

2. What is considered recurrent pregnancy loss?

Generally, two or more pregnancy losses before 20–24 weeks of gestation.

3. Why might endometriosis affect pregnancy outcomes?

Proposed mechanisms include chronic inflammation altering endometrial receptivity, immune system dysfunction, and effects on the egg and embryo in natural conception.

4. Does IVF reduce the miscarriage risk associated with endometriosis?

Some proposed mechanisms specific to natural conception may be bypassed with IVF, though this doesn’t necessarily eliminate all endometriosis-related risk.

5. What percentage of recurrent miscarriage cases have no identified cause?

Roughly half of RPL cases remain unexplained even after thorough evaluation, regardless of endometriosis status.

6. Should I get an RPL work-up if I have endometriosis and recurrent miscarriage?

Yes, a comprehensive evaluation remains important, since endometriosis shouldn’t be assumed as the sole explanation without ruling out other factors.

7. Does treating endometriosis prevent future miscarriages?

This isn’t well established — endometriosis treatment is generally aimed at symptom relief and improving fertility, not specifically proven to prevent miscarriage.

8. What did the Scottish cohort study find about endometriosis and pregnancy?

It found that endometriosis predisposed women to a higher risk of early pregnancy loss and later pregnancy complications, based on over 5,000 women with surgically confirmed disease.

9. Is there research disagreeing with a strong endometriosis-miscarriage link?

Yes, a systematic review found pregnancy complications related to endometriosis to be rare, with no strong evidence of major detrimental effects overall.

10. Can chronic endometritis also contribute to recurrent miscarriage?

Yes, it’s another condition associated with altered endometrial receptivity and early pregnancy loss, sometimes considered alongside endometriosis in an evaluation.

11. Does adenomyosis share similar mechanisms with endometriosis regarding miscarriage risk?

Yes, chronic inflammation affecting endometrial receptivity is a proposed shared mechanism among endometriosis, adenomyosis, and chronic endometritis.

12. What tests are typically done for recurrent miscarriage?

Genetic testing, uterine imaging, hormonal testing, and blood clotting disorder screening are commonly included in a comprehensive evaluation.

13. Can immune system factors contribute to miscarriage in endometriosis patients?

Yes, immune dysfunction affecting the endometrium’s tolerance toward the embryo is a proposed, actively researched mechanism.

14. Should I choose IVF over natural conception if I have endometriosis and recurrent miscarriage?

This is a decision to discuss with your specialist, weighing your specific evaluation findings, fertility goals, and the nuanced evidence around natural conception versus IVF.

15. Is endometriosis-related miscarriage risk the same for everyone with the condition?

No, individual risk likely varies based on endometriosis severity, location, and other personal factors, alongside the genuinely mixed broader research.

16. Can research on shared genes between endometriosis and RPL help future treatment?

Yes, this is an active area of research aiming to identify biomarkers and potential therapeutic targets, though it’s still developing.

17. Does having endometriosis automatically mean I’ll have a miscarriage?

No, endometriosis doesn’t guarantee a miscarriage will happen — it’s associated with a statistically higher risk in some studies, not a certainty.

18. Is fresh or frozen embryo transfer better for women with endometriosis?

Some research has noted differences in miscarriage rates between fresh and frozen transfer in endometriosis patients, though this should be discussed individually with your specialist.

19. Can lifestyle factors influence miscarriage risk in endometriosis patients?

General reproductive health factors may play a role, though the primary research focus has been on inflammatory and immune mechanisms specific to the condition.

20. Should both endometriosis and other RPL causes be investigated together?

Yes, a comprehensive evaluation considering multiple potential factors together provides a more complete picture than focusing on endometriosis alone.

21. Is this an actively evolving area of medical research?

Yes, genuinely so — new studies continue to explore the mechanisms and treatment implications of the endometriosis-miscarriage relationship.

22. Where can I get a comprehensive recurrent miscarriage evaluation in Hyderabad?

Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers comprehensive recurrent pregnancy loss evaluation at both our Kondapur and Attapur clinics.

Conclusion

The link between endometriosis and recurrent miscarriage is real enough to take seriously, but not settled enough to treat as the automatic explanation for every case. The most useful path forward is a comprehensive evaluation that considers endometriosis as one possible factor among several — giving you an honest, complete picture rather than a single, oversimplified answer.

Get a Comprehensive Evaluation

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre will help you understand the full picture behind your recurrent pregnancy loss.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

If you’ve experienced failed embryo implantation despite good-quality embryos, you may have come across the ERA test as a possible explanation — and a possible fix. Before you consider it, it’s worth knowing something important: the evidence behind this test has shifted significantly in recent years, and not in the direction its early popularity suggested.

What Is the ERA Test?

The Endometrial Receptivity Analysis (also called the Endometrial Receptivity Array) is a test that analyses the expression of 238 specific genes in a sample of your endometrial tissue, aiming to determine whether your endometrium is:

  • Receptive — the optimal time for embryo transfer
  • Pre-receptive — suggesting more progesterone exposure time is needed before transfer
  • Post-receptive — suggesting less progesterone exposure time would be better

The idea is to identify your personal “window of implantation” (WOI) — the theory being that some women’s biological window doesn’t align with the standard timing used in most IVF protocols, and that personalising your embryo transfer timing (pET) to this window could improve your chances.

How Is the ERA Test Done?

A small endometrial tissue sample is taken via biopsy, typically during a mock (non-transfer) cycle that mimics your actual treatment protocol. This tissue is then analysed for its gene expression profile, and the result guides the recommended timing for your actual embryo transfer in a subsequent cycle.

What Does Current Evidence Actually Show?

This is where honesty matters far more than following the test’s early popularity.

The Major Randomized Trial Found No Benefit

A large, high-quality, double-blind randomized controlled trial — using vitrified, genetically normal (euploid) embryos — found no significant advantage in live birth rates, or any other positive clinical outcome, when embryo transfer timing was guided by ERA results compared to standard timing. Reported live birth rates were statistically similar between groups in multiple analyses of this data.

A Meta-Analysis Confirmed the Pattern

A subsequent meta-analysis reviewing the broader body of research on ERA-guided transfer similarly concluded that it does not confer a significant advantage over standard transfer timing.

A Critical Reanalysis Raised an Even More Serious Concern

Perhaps most striking: a detailed reanalysis of the major randomized trial’s data, published in a peer-reviewed journal, argued that the ERA test failed to accurately identify the window of implantation as intended — and that personalised embryo transfer based on its results may have actually reduced birth rates rather than improved them. The authors explicitly recommended that clinical use of ERA-guided personalised embryo transfer be discontinued outside of a properly controlled research setting with full patient informed consent.

Why Did ERA Become Popular Before This Evidence Existed?

This is a genuinely important pattern to understand: ERA saw rapid, widespread clinical adoption after its introduction, before the large, rigorous randomized trials needed to properly evaluate it had been completed. This isn’t unique to ERA — a similar story played out decades earlier with histological (microscope-based) assessment of endometrial receptivity, which was also widely used before being shown unreliable once properly studied.

Is There Any Population Where ERA Might Still Help?

This is genuinely still being studied. Most of the strong negative evidence above comes from general IVF populations, not specifically women with recurrent implantation failure (RIF) — the group ERA was originally intended to help most. As of current research, a dedicated, adequately powered randomized trial specifically in RIF patients has been harder to find, though at least one such trial is currently registered and underway, with results not yet available.

In other words: for most patients, current evidence doesn’t support ERA-guided transfer timing. For the specific RIF population, the question remains more genuinely open, pending dedicated research — but even here, it’s not something with confirmed proven benefit.

What Does This Mean for You?

If a clinic recommends the ERA test, it’s reasonable to ask directly:

  • What specific evidence supports this test for my particular situation?
  • Am I part of a population (like RIF) where the evidence is still evolving, or a general population where recent trials have shown no benefit?
  • What would change about my treatment plan based on the result, and is that change itself evidence-based?

A good specialist should be able to answer these questions honestly, rather than presenting ERA as a routine, proven solution for implantation difficulties.

What About Cost?

ERA testing typically adds meaningful cost on top of your IVF cycle, given the additional biopsy and specialised laboratory analysis involved. Given the current evidence, it’s worth having a clear, direct conversation about cost versus expected benefit for your specific situation, rather than assuming it’s a routine, worthwhile add-on. Costs vary by clinic and lab, so ask for a specific, itemised estimate if you’re considering it.

Our Approach to Endometrial Receptivity Testing at Sree Swapna Fertility Centre

As one of the best fertility centers in Hyderabad, we believe patients deserve current, honest evidence — not outdated enthusiasm for a test that hasn’t held up under rigorous study.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, with over 15 years of experience in reproductive medicine. For patients experiencing recurrent implantation failure, our approach involves a comprehensive evaluation — considering embryo quality, uterine structural factors, and other potential contributors — rather than defaulting to any single test, including ERA, as an automatic explanation or fix.

Both our Kondapur and Attapur clinics stay current with evolving reproductive medicine research, and we’re committed to explaining exactly what the evidence does and doesn’t support before recommending any additional testing.

Frequently Asked Questions

1. What is the ERA test?

It’s a test analysing endometrial gene expression to determine whether the uterine lining is in its optimal “window of implantation” for embryo transfer.

2. Does the ERA test improve IVF success rates?

Current strong randomized trial evidence shows no significant improvement in live birth rates for general IVF populations, and one reanalysis suggests it may even reduce success in some cases.

3. Is the ERA test still worth doing for recurrent implantation failure?

This remains a more open question specifically for this population, as dedicated, adequately powered trials in RIF patients are still ongoing, with results not yet fully available.

4. How is the ERA test performed?

Through an endometrial tissue biopsy, typically during a mock cycle that mimics your actual treatment protocol, followed by gene expression analysis.

5. What does a “pre-receptive” or “post-receptive” ERA result mean?

It suggests your endometrium may need more or less progesterone exposure time before transfer, according to the test’s underlying theory.

6. Why did ERA become popular before strong evidence existed?

It saw rapid clinical adoption shortly after introduction, before the large randomized trials needed to properly evaluate its benefit had been completed — a pattern seen with some earlier receptivity tests too.

7. What did the major randomized trial on ERA find?

It found no significant advantage in live birth rates or other clinical outcomes when embryo transfer was timed according to ERA results, compared to standard timing.

8. Did any research suggest ERA could actually be harmful?

Yes, a detailed reanalysis of trial data suggested ERA failed to accurately identify the window of implantation, and that personalised transfer based on it may have reduced birth rates in that trial.

9. Should I ask my doctor why ERA is being recommended?

Yes, it’s a reasonable and important question — ask what specific evidence supports it for your situation, and what would change in your treatment based on the result.

10. Is the ERA test expensive?

It typically adds meaningful cost to an IVF cycle due to the biopsy and specialised analysis involved — ask for a specific, itemised estimate from your clinic.

11. Is ERA testing banned or discontinued anywhere?

No formal ban exists, though some researchers have explicitly recommended discontinuing routine clinical use outside of controlled research settings, based on current evidence.

12. What is the “window of implantation”?

It refers to the specific time period when the endometrium is theoretically most receptive to embryo implantation.

13. Does ERA testing use euploid (genetically normal) embryos in research?

Yes, the major randomized trial specifically used euploid embryos to remove embryo quality as a confounding factor in assessing ERA’s benefit.

14. What other factors should be considered for recurrent implantation failure?

Embryo quality, uterine structural issues, chronic endometritis, and other factors should all be part of a comprehensive evaluation, not just endometrial receptivity timing.

15. Is there an ongoing trial specifically studying ERA for RIF patients?

Yes, at least one registered randomized trial is currently investigating this specific population, though results aren’t yet available.

16. Should I decline ERA testing if my clinic recommends it?

This is a personal decision best made after understanding the current evidence and discussing it directly with your specialist, rather than a decision to make alone.

17. Does a meta-analysis support ERA’s clinical use?

No, a meta-analysis reviewing the broader evidence concluded that ERA-guided transfer doesn’t confer a significant advantage over standard timing.

18. Is this similar to other reproductive medicine tests that were later questioned?

Yes, histological (microscope-based) endometrial receptivity assessment was similarly popular for decades before rigorous studies showed it unreliable.

19. Can ERA results change between cycles?

This is part of the ongoing scientific debate about the test’s reliability, since a stable, accurate result is important for the test’s underlying premise to hold.

20. Does Sree Swapna Fertility Centre recommend ERA testing routinely?

No, we base testing recommendations on current evidence and your specific clinical picture, rather than offering it as a routine add-on.

21. What should I focus on instead if I’m facing recurrent implantation failure?

A comprehensive evaluation covering embryo quality, uterine health, and other potential factors, guided by a specialist who stays current with evolving research.

22. Where can I get an evidence-based evaluation for implantation failure in Hyderabad?

Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers comprehensive, evidence-based evaluation for recurrent implantation failure at both our Kondapur and Attapur clinics.

Conclusion

The ERA test’s story is a genuinely important lesson in reproductive medicine: early promise and rapid adoption don’t always hold up once rigorous randomized trials are completed. Current evidence doesn’t support routine ERA-guided embryo transfer for most patients, though the question remains more open for recurrent implantation failure specifically. The most valuable thing you can do is ask direct questions about the evidence behind any test recommended to you.

Get an Honest, Evidence-Based Fertility Evaluation

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre will explain exactly what current research supports before recommending any additional testing.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

We want to start with complete transparency: definitive endometrial (uterine) cancer treatment — surgical staging, radiation, and chemotherapy — is delivered by a gynaecologic oncologist, working within a specialised cancer care team. This is the internationally recognised standard of care, reflected in guidelines from bodies including the National Comprehensive Cancer Network (NCCN) and the European Society of Gynaecological Oncology (ESGO).

What this article offers is an accurate, evidence-based overview of how endometrial cancer is treated — so you understand your options and questions to ask — along with a clear explanation of where general gynaecology and fertility medicine genuinely contribute to your care.

The Standard Treatment Approach

According to current international treatment guidelines, the standard first-line treatment for endometrial cancer is:

Total hysterectomy with bilateral salpingo-oophorectomy (TH/BSO), combined with surgical staging, which typically includes assessment of the pelvic and para-aortic lymph nodes.

Surgical Approach Options

This surgery can be performed through several approaches:

  • Abdominal (open) surgery
  • Laparoscopic surgery
  • Robotic-assisted surgery
  • Vaginal surgery, in select cases

Research comparing these approaches has found robotic hysterectomy may offer advantages in some outcomes — including reduced complications, shorter hospital stay, and less blood loss — compared with open or standard laparoscopic surgery, according to recent meta-analyses, though the right approach depends on individual staging and surgical factors determined by your gynaecologic oncology team.

Additional (Adjuvant) Treatment

Depending on your specific stage and pathology findings after surgery, additional treatment may be recommended:

  • Radiation therapy — including external beam radiation therapy (EBRT) and/or brachytherapy (internal radiation)
  • Chemotherapy — generally for higher-stage or higher-risk disease
  • Hormone therapy — sometimes considered for select patients, particularly those with lower-grade disease who aren’t candidates for immediate surgery

Current protocols determine adjuvant treatment based on your specific FIGO stage, tumour grade, and — increasingly — molecular subtype, following the 2023 update to international staging guidelines.

Fertility-Sparing Treatment: An Important, Highly Selective Option

For a small subset of young patients — generally those with grade 1 (sometimes grade 2), stage IA (non-invasive) endometrioid endometrial cancer who strongly wish to preserve fertility — fertility-sparing treatment may be considered as an alternative to immediate hysterectomy.

It’s important to understand: this is genuinely not the standard of care. It’s reserved for carefully selected patients, requires thorough counselling about the risks involved, and demands close, ongoing oncological surveillance throughout treatment.

Fertility-Sparing Treatment Options

  • Oral progestins (such as medroxyprogesterone acetate or megestrol acetate)
  • Levonorgestrel-releasing intrauterine device (LNG-IUD), sometimes combined with systemic progestins
  • GnRH agonists, in some protocols
  • Hysteroscopic resection followed by progestin therapy — one specific approach shown in research to achieve a high complete response rate, though with a meaningful recurrence rate that requires careful, ongoing monitoring

A comprehensive review of 18 studies covering nearly 24,000 patients found complete response rates ranging widely (18–100%) and recurrence rates also varying significantly (0–81.8%) depending on the specific protocol and patient selection — underscoring how individualised and closely monitored this approach needs to be.

A critical point: even among patients pursuing fertility-sparing treatment, the decision about when — or whether — to eventually proceed with definitive surgery once childbearing is complete remains a carefully individualised oncological decision, made in ongoing consultation with a gynaecologic oncology team.

How Diagnosis Leads to Treatment Planning

  • Endometrial biopsy confirms the histological diagnosis
  • Imaging (transvaginal ultrasound, and often MRI) helps assess the extent of disease before surgery
  • Definitive staging, however, can only be confirmed after surgery itself
  • Molecular/genomic classification, now incorporated into 2023 FIGO staging, increasingly informs both prognosis and treatment planning

Where General Gynaecology and Fertility Medicine Fit Into Your Care

We want to be precise about this, since it matters for your safety and your outcome:

What requires a gynaecologic oncologist: Diagnosis confirmation and staging surgery, radiation therapy, chemotherapy, and ongoing oncological surveillance — including for patients pursuing fertility-sparing treatment.

Where general gynaecology and fertility medicine contribute:

  • Recognising abnormal uterine bleeding — the most common early symptom — and pursuing prompt initial evaluation
  • Initial diagnostic imaging and endometrial biopsy
  • Coordinating referral to an appropriate gynaecologic oncology team without delay
  • Supporting fertility preservation conversations for young patients, working alongside — not instead of — the treating oncology team

Endometrial Health Evaluation at Sree Swapna Fertility Centre

As one of the best fertility centers in Hyderabad, we take abnormal uterine bleeding seriously as a symptom warranting prompt evaluation, particularly given how meaningfully early detection affects endometrial cancer outcomes.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, with over 15 years of experience in gynaecology. Both our Kondapur and Attapur clinics offer in-house transvaginal ultrasound and endometrial biopsy for initial evaluation, with prompt, coordinated referral to gynaecologic oncology whenever findings raise concern — and ongoing fertility preservation support for younger patients navigating this diagnosis alongside their oncology care.

Frequently Asked Questions

1. What is the standard treatment for endometrial cancer?

The standard first-line treatment is total hysterectomy with bilateral salpingo-oophorectomy and surgical staging, performed by a gynaecologic oncologist.

2. Does Sree Swapna Fertility Centre perform endometrial cancer surgery?

No, staging surgery, radiation, and chemotherapy require a gynaecologic oncology team. We provide initial evaluation and coordinate referral for definitive treatment.

3. Is fertility-sparing treatment an option for everyone with endometrial cancer?

No, it’s reserved for a carefully selected group of young patients with early-stage, low-grade disease who strongly wish to preserve fertility, and is not the standard of care.

4. What does fertility-sparing treatment for endometrial cancer involve?

Options include oral progestins, an LNG-IUD, sometimes combined with hysteroscopic resection, all under close, ongoing oncological monitoring.

5. How effective is fertility-sparing treatment?

Research shows widely varying complete response and recurrence rates depending on the specific protocol, which is why individualised, closely monitored care is essential.

6. Is robotic surgery better than open surgery for endometrial cancer?

Some research suggests robotic hysterectomy may offer advantages like fewer complications and shorter hospital stay, though the right approach depends on individual factors determined by your surgical team.

7. What is surgical staging in endometrial cancer treatment?

It involves assessing pelvic and para-aortic lymph nodes during surgery to determine how far the cancer has spread, guiding further treatment decisions.

8. When is radiation therapy used for endometrial cancer?

It’s typically used as adjuvant treatment based on stage and risk factors, or as primary treatment for patients who aren’t surgical candidates.

9. When is chemotherapy recommended?

Generally for higher-stage or higher-risk endometrial cancer, as determined by your treating oncology team.

10. What is the most common early symptom of endometrial cancer?

Abnormal uterine bleeding, particularly bleeding after menopause, is the most common early warning sign.

11. Can ovaries be preserved during endometrial cancer surgery?

In select premenopausal patients with low-grade, stage IA disease, ovarian preservation may be considered, though it’s not recommended for those with genetic risk factors like BRCA mutations or Lynch syndrome.

12. What is the 2023 FIGO staging update?

It incorporated molecular/genomic classification alongside traditional anatomical staging, improving prognosis prediction accuracy.

13. Can definitive diagnosis be made before surgery?

Imaging and biopsy can strongly suggest the diagnosis and stage, but definitive staging is generally confirmed only after surgery.

14. Is fertility-sparing treatment guaranteed to work?

No, response and recurrence rates vary significantly across studies, and it requires strict counselling and close, ongoing monitoring.

15. What happens after fertility-sparing treatment is complete?

The decision about proceeding with definitive surgery afterward is individualised and made in ongoing consultation with your gynaecologic oncology team.

16. Should every case of abnormal bleeding be evaluated for endometrial cancer?

Any abnormal or postmenopausal bleeding should be evaluated by a doctor, though most cases have benign causes.

17. Can general gynaecology help coordinate care during endometrial cancer treatment?

Yes, particularly around initial evaluation and fertility preservation support, working alongside your oncology team.

18. What imaging is used before endometrial cancer surgery?

Transvaginal ultrasound and often MRI are used to assess disease extent before surgical planning.

19. Is genetic testing relevant to endometrial cancer treatment decisions?

Yes, particularly for decisions like ovarian preservation, where genetic risk factors such as Lynch syndrome are an important consideration.

20. Can younger women get endometrial cancer?

Yes, though less common than in postmenopausal women, which is exactly why fertility-sparing treatment options have become an important area of research.

21. How is a gynaecologic oncologist different from a general gynaecologist?

A gynaecologic oncologist has specialised training in cancer staging, surgery, and coordinated oncological treatment, beyond general gynaecological practice.

22. Where can I get initial evaluation for abnormal bleeding in Hyderabad?

Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers transvaginal ultrasound and endometrial biopsy at both our Kondapur and Attapur clinics, with prompt oncology referral when needed.

Conclusion

Endometrial cancer treatment follows well-established, internationally recognised protocols — primarily surgical staging, with radiation and chemotherapy added based on individual risk factors, and select fertility-sparing options for carefully chosen younger patients. Getting to a qualified gynaecologic oncology team promptly, following early symptom recognition, remains one of the most important factors in a good outcome.

Concerned About Abnormal Bleeding or Need Fertility Preservation Support?

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre can provide prompt evaluation and coordinate specialist oncology care alongside fertility preservation support.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

A newer class of oral hormonal medication has become available for endometriosis treatment in India — a GnRH (gonadotropin-releasing hormone) antagonist, available here since 2024 following clinical trials conducted specifically in Indian patients. If your doctor has mentioned this option, it’s worth understanding exactly how it works, what it can realistically offer, and — just as importantly — when it isn’t the right choice.

What Is This GnRH Antagonist Medication?

This is an oral GnRH antagonist, originally approved internationally in 2018 and now available in India, including as a locally manufactured formulation.

Unlike GnRH agonists (an older class of injectable medication for endometriosis), a GnRH antagonist works by directly blocking GnRH receptors, giving doctors more precise, dose-dependent control over hormone suppression — rather than the more abrupt, complete suppression seen with agonist medications.

How Does It Work?

This medication blocks GnRH receptor signalling in the pituitary gland, which reduces the release of FSH and LH (the hormones that stimulate the ovaries). This, in turn, lowers oestradiol and progesterone levels — reducing the hormonal stimulation that drives endometriosis-related inflammation and pain.

What Dosing Options Are Available?

This treatment comes in two approved doses, allowing therapy to be individualised:

  • A lower once-daily dose — milder hormone suppression, generally approved for longer-term use (up to 24 months)
  • A higher twice-daily dose — more complete suppression, generally used for a shorter duration due to a greater impact on bone density over time

What Symptoms Does This Treatment Help With?

Clinical studies have shown this GnRH antagonist effectively reduces:

  • Dysmenorrhoea (period pain)
  • Non-menstrual pelvic pain
  • Dyspareunia (pain during intercourse)
  • Reliance on rescue pain medication, such as NSAIDs or opioids

How Does It Compare to Other Hormonal Options?

This medication’s main advantage over GnRH agonists is a milder hypoestrogenic effect — meaning side effects related to low oestrogen tend to be less pronounced, since the suppression is partial and dose-adjustable rather than complete.

Compared to progestin-based therapy (another common hormonal option for endometriosis), this treatment works through a different mechanism and is generally considered when progestins or other first-line hormonal options haven’t adequately controlled symptoms.

Side Effects and Safety Considerations

  • Bone mineral density loss, particularly with the higher twice-daily dose over extended use — this is why treatment duration is capped depending on dosage
  • Hot flashes, a common hypoestrogenic side effect
  • Mood changes, reported in some patients
  • Not suitable if you’re trying to conceive, since it suppresses ovulation

Regular monitoring, including periodic discussion of bone health for longer-term use, is a reasonable part of treatment with your specialist.

An Important, Honest Caution

Here’s something worth knowing directly: some clinical commentary from within India has raised a genuine concern that this GnRH antagonist is, at times, prescribed as a “convenient” option by doctors who don’t specialise in surgical endometriosis treatment — even in situations where surgery might actually be the more appropriate path forward, particularly for deep infiltrating endometriosis or cases where a specific, correctable lesion has been identified.

It’s also worth understanding plainly: this medication does not cure endometriosis. It manages symptoms while you’re taking it, and for many patients, symptoms return — sometimes significantly — once treatment stops, since the underlying tissue isn’t removed.

This isn’t a reason to avoid this treatment if it’s genuinely the right fit for your situation — but it is a reason to ask your doctor directly: is medication being recommended because surgery isn’t appropriate for my case, or simply because it’s the easier option to prescribe?

What Does This Treatment Cost in India?

As a relatively newer medication class in the Indian market, this GnRH antagonist carries a meaningfully higher cost than older, more established hormonal options like progestin-based therapy or combined oral contraceptives. Reported costs for a typical treatment course have been described as a significant expense — this is worth discussing directly and transparently with your prescribing doctor, including exactly how many months of treatment are being recommended and why, before starting.

Who Might This Treatment Be a Good Option For?

  • Women with moderate-to-severe endometriosis pain who haven’t responded adequately to first-line options like NSAIDs, combined contraceptives, or progestin-based therapy
  • Women not currently trying to conceive
  • Cases where a milder hypoestrogenic side-effect profile is preferred over GnRH agonist treatment

Who Should Get a Second Opinion Before Starting This Treatment?

  • If deep infiltrating endometriosis is suspected, since surgical excision may offer more definitive, longer-term relief
  • If you haven’t yet had a thorough diagnostic evaluation, including detailed imaging
  • If cost and treatment duration haven’t been clearly explained upfront

GnRH Antagonist Therapy and Endometriosis Care at Sree Swapna Fertility Centre

As one of the best fertility centers in Hyderabad, we consider this treatment as one option within a broader, individualised endometriosis treatment plan — not a default prescription offered in place of a proper diagnostic work-up.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, and is a trained laparoscopic surgeon with over 15 years of experience. Because she combines both medical and surgical expertise, treatment recommendations are based on your actual imaging findings and disease extent — not limited to whichever option is easiest to prescribe.

Both our Kondapur and Attapur clinics offer thorough diagnostic evaluation before recommending this therapy, other hormonal options, or surgical treatment, so you understand exactly why a particular path is being suggested for your specific case.

Frequently Asked Questions

1. Is this GnRH antagonist medication available in India?

Yes, it has been available in India since 2024, following clinical trials conducted in Indian patients, including locally manufactured formulations.

2. What type of medication is a GnRH antagonist?

It’s an oral medication that blocks hormone receptor signalling to reduce oestrogen levels and manage endometriosis-related pain.

3. Does this treatment cure endometriosis?

No, it manages symptoms while being taken, but doesn’t remove the underlying tissue, and symptoms commonly return after stopping treatment.

4. How is a GnRH antagonist different from a GnRH agonist?

A GnRH antagonist generally causes milder hypoestrogenic side effects, since it allows for partial, dose-adjustable suppression rather than complete suppression.

5. What are the two available dosing options?

A lower once-daily dose (milder, longer-term use) and a higher twice-daily dose (stronger suppression, shorter recommended duration).

6. Can I take this medication while trying to conceive?

No, it suppresses ovulation and isn’t suitable for women actively trying to conceive.

7. What are the main side effects?

Bone mineral density loss with prolonged higher-dose use, hot flashes, and mood changes are among the recognised side effects.

8. Is this treatment expensive in India?

Yes, as a newer medication class, it typically costs meaningfully more than established options like progestin-based therapy — discuss exact costs and treatment duration with your prescribing doctor.

9. Is this always the right choice for endometriosis pain?

Not necessarily — it’s most appropriate after first-line options haven’t worked, and it’s important to first rule out cases where surgery might be more suitable.

10. Can this treatment be used for deep infiltrating endometriosis?

It can help manage symptoms, but surgical excision is often considered more definitive for deep infiltrating disease — this should be discussed based on your specific imaging findings.

11. How long can I take this medication?

Approved duration depends on the dose — up to 24 months for the lower dose, with a shorter recommended duration for the higher dose due to bone density considerations.

12. Should I get a second opinion before starting this treatment?

Yes, particularly if you haven’t had thorough imaging, or if deep infiltrating endometriosis is suspected.

13. Does this treatment affect bone density?

Yes, particularly with prolonged use of the higher dose, which is why monitoring and duration limits are part of appropriate treatment.

14. Is a GnRH antagonist better than progestin-based therapy?

Neither is universally “better” — they work through different mechanisms, and the right choice depends on your specific symptoms, prior treatment response, and doctor’s assessment.

15. What symptoms does this treatment specifically help with?

Period pain, non-menstrual pelvic pain, and pain during intercourse, along with reducing reliance on additional pain medication.

16. Can this treatment be combined with surgery?

Yes, it can be used before or after surgery in some treatment plans, depending on your specific situation.

17. Will my symptoms return after stopping this medication?

Commonly, yes, since the underlying endometriosis tissue isn’t removed by the medication itself.

18. Is this medication manufactured in India?

Yes, following its introduction to the Indian market, locally manufactured formulations have become available.

19. What questions should I ask before starting this treatment?

Ask why it’s being recommended over other options, how long treatment will last, what it will cost, and whether surgery has been properly considered for your case.

20. Is this treatment suitable for all endometriosis patients?

No, it’s generally considered for specific symptom patterns after other options haven’t worked, and isn’t suitable for women trying to conceive.

21. Does this treatment require ongoing monitoring?

Yes, particularly bone health considerations for longer-term or higher-dose use, which should be discussed with your prescribing doctor.

22. Where can I get an individualised endometriosis treatment plan in Hyderabad?

Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers thorough diagnostic evaluation and individualised treatment planning at both our Kondapur and Attapur clinics.

Conclusion

This GnRH antagonist offers a genuinely useful, newer option for managing endometriosis pain in India — but it works best as part of a properly individualised treatment plan, not a default prescription offered in place of thorough diagnosis. If you’re considering it, ask clearly why it’s being recommended for your specific situation, and whether surgical options have been properly weighed alongside it.

Discuss Whether This Treatment Is Right for You

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre will help you understand all your options — medical and surgical — before recommending a path forward.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

Egg freezing has become a genuinely mainstream fertility preservation option — but it’s also one of the most misunderstood, largely because of how it’s often marketed. Before deciding if it’s right for you, it’s worth understanding the real process, and the honest numbers behind your chances of success.

What Is Egg Freezing?

Egg freezing (medically called oocyte cryopreservation) involves retrieving unfertilised eggs from your ovaries and preserving them through vitrification — a rapid-freezing technique — so they can potentially be used later, fertilised through IVF when you’re ready to try for pregnancy.

Who Considers Egg Freezing?

  • Elective (planned) freezing — women who want to preserve fertility options while focusing on career, relationships, or personal timing
  • Before cancer treatment — chemotherapy or radiation can significantly affect ovarian function, making pre-treatment egg freezing an important consideration
  • Genetic or medical conditions associated with earlier-than-typical menopause or reduced ovarian reserve
  • Before certain gynaecological surgeries that might affect ovarian function

What Does the Egg Freezing Process Involve?

  1. Ovarian stimulation: Hormonal injections over roughly 10–14 days stimulate your ovaries to develop multiple eggs, rather than the single egg typically released each month
  2. Monitoring: Regular ultrasound and blood tests track follicle development and hormone levels, allowing adjustments to medication as needed
  3. Trigger injection: A specific hormone injection times final egg maturation before retrieval
  4. Egg retrieval: A short procedure performed under sedation, using ultrasound guidance to collect eggs from the ovaries — typically taking 15–30 minutes
  5. Vitrification: Mature eggs are rapidly frozen immediately after retrieval, using a technique associated with high post-thaw survival rates
  6. Storage: Eggs remain frozen until you’re ready to use them, sometimes years later

What Are Your Realistic Chances of Success?

This is where honest, specific numbers matter far more than vague reassurance.

Each Individual Egg Has a Modest Chance

According to ASRM guidance, each individual frozen egg carries roughly a 2–12% chance of eventually resulting in a live birth. This is exactly why the number of eggs frozen — not just the fact that you froze eggs at all — matters so much.

Age Is the Single Biggest Factor

Research consistently shows:

  • Women under 35 may need roughly 9–15 mature eggs frozen for an estimated 70% chance of at least one live birth, according to various published studies
  • Women in their late 30s often need close to double that number for similar odds
  • Women aged 40 and older may need considerably more — some studies suggest 25 eggs or more — and multiple stimulation cycles are often required to reach that number

Real-World Data Adds Important Context

One study following women who underwent elective egg freezing found that only about 16% eventually returned to use their frozen eggs; those who did saw an average post-thaw survival rate of around 74%, a fertilisation rate of about 67%, and a live birth rate per embryo transfer of around 35% — notably, this same research found live birth rates were significantly higher across all ages when 15 or more eggs were frozen per patient.

Frozen vs. Fresh Eggs: Encouraging News

ASRM’s evidence review found that when frozen eggs are eventually used in IVF, pregnancy rates per transfer are comparable to using fresh eggs, and resulting babies appear just as healthy — reassuring news that frozen eggs aren’t a “lesser” option once thawed and used appropriately.

The Honest Bottom Line on Success

ASRM’s Ethics Committee has been explicit: elective egg freezing is an ethically sound way to try to preserve future fertility options, but it cannot promise a future baby. Your actual odds depend heavily on your age at freezing and how many eggs you’re able to bank — sometimes requiring more than one stimulation cycle to reach a meaningful number, particularly if you’re freezing eggs in your late 30s or beyond.

What Affects the Cost of Egg Freezing?

  • Number of stimulation cycles needed to bank an adequate number of eggs, which varies significantly by age and ovarian reserve
  • Medication costs, which can vary based on your specific stimulation protocol and how your body responds
  • Vitrification and initial storage fees
  • Ongoing annual storage fees, since eggs are typically stored long-term until you’re ready to use them
  • Future thaw, fertilisation, and embryo transfer costs, which are separate from the initial freezing process itself

For an accurate, personalised cost estimate — including how many cycles you might realistically need based on your age and ovarian reserve — it’s best to discuss your specific situation directly with your fertility specialist.

Timing: When Should You Consider Freezing?

Given how strongly age affects outcomes, earlier tends to be better if egg freezing is something you’re seriously considering — ideally before your mid-30s, since success rates decline meaningfully after that point. That said, this is a deeply personal decision, and a proper AMH and antral follicle count evaluation can help you and your specialist understand your specific starting point, rather than relying on age alone.

Egg Freezing at Sree Swapna Fertility Centre

As one of the best fertility centers in Hyderabad for fertility preservation, we believe in giving patients honest, age-specific numbers — not generic reassurance — before they commit to egg freezing.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, with over 15 years of experience in reproductive medicine. Our approach includes a thorough ovarian reserve assessment (AMH and antral follicle count) before your first cycle, so you understand realistically how many eggs you might need to bank, and how many cycles that could involve.

Both our Kondapur and Attapur clinics offer the full stimulation, retrieval, and vitrification process in-house, supported by our CLIA-certified embryology lab.

Frequently Asked Questions

1. What is egg freezing?

It’s the process of retrieving and freezing unfertilised eggs through vitrification, so they can potentially be used later for IVF.

2. Does egg freezing guarantee a future baby?

No, ASRM is explicit that egg freezing cannot promise a future baby — success depends heavily on age at freezing and the number of eggs banked.

3. How many eggs should I freeze?

This depends on your age — women under 35 may need roughly 9–15 eggs for a good chance of one live birth, while women in their late 30s or 40s often need considerably more.

4. What is the chance a single frozen egg results in a live birth?

According to ASRM guidance, each individual egg carries roughly a 2–12% chance of eventually resulting in a live birth.

5. Is there a best age to freeze eggs?

Generally, earlier is better — ideally before the mid-30s, since egg quantity and quality decline meaningfully with age.

6. How long does the egg freezing process take?

Ovarian stimulation typically takes 10–14 days, followed by a short retrieval procedure, making the full active process roughly 2–3 weeks per cycle.

7. Is egg retrieval painful?

It’s performed under sedation, so most women don’t experience pain during the procedure itself, though some cramping or discomfort afterward is common.

8. Do frozen eggs work as well as fresh eggs when used later?

Yes, ASRM’s evidence review found comparable pregnancy rates and healthy outcomes between frozen and fresh eggs when used appropriately in IVF.

9. How many women who freeze their eggs actually use them later?

One study found only around 16% of women who froze eggs electively returned to use them, though this varies by individual circumstances.

10. Does freezing more eggs really improve my chances?

Yes, research consistently shows live birth rates are significantly higher when 15 or more eggs are frozen, regardless of age at freezing.

11. Will I need more than one stimulation cycle?

Possibly, particularly if you’re freezing eggs in your late 30s or older, since more eggs are typically needed to reach a meaningful chance of success at that age.

12. What is vitrification?

It’s a rapid-freezing technique used to preserve eggs, associated with high post-thaw survival rates compared to older freezing methods.

13. How long can eggs remain frozen?

Eggs can typically remain viable in frozen storage for many years, though storage duration policies vary by clinic and country regulations.

14. What tests are done before starting egg freezing?

AMH and antral follicle count assessments help estimate your ovarian reserve and predict how many eggs you might retrieve per cycle.

15. Is egg freezing recommended before cancer treatment?

Yes, it’s a well-established option for women facing chemotherapy or radiation, which can significantly affect future fertility.

16. Does egg freezing affect my current fertility or ovarian reserve?

No, the stimulation and retrieval process doesn’t reduce your remaining long-term ovarian reserve beyond the eggs collected during that cycle.

17. What happens to the eggs during the freezing process if I decide not to use them?

Storage arrangements, including disposal or continued storage options, should be discussed clearly with your clinic as part of your consent process.

18. Is egg freezing the same as embryo freezing?

No, egg freezing preserves unfertilised eggs, while embryo freezing involves fertilising eggs with sperm first — a decision that depends on your relationship status and preferences.

19. Can I get a personalised estimate of how many eggs I might need?

Yes, based on your age, AMH, and antral follicle count, your specialist can give you a more individualised estimate than general population averages.

20. Does insurance typically cover egg freezing in India?

Coverage varies significantly by insurer and policy — confirm directly with your provider regarding your specific situation.

21. What ongoing costs are involved after the initial freezing cycle?

Annual storage fees are typically ongoing, along with future costs for thawing, fertilisation, and embryo transfer when you’re ready to use the eggs.

22. Where can I get egg freezing treatment in Hyderabad?

Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers egg freezing with in-house stimulation, retrieval, and vitrification at both our Kondapur and Attapur clinics.

Conclusion

Egg freezing is a genuinely valuable option for preserving future fertility choices — but it works best when approached with honest, age-specific expectations rather than a vague sense of “insurance” against future infertility. Understanding how many eggs you might realistically need, and how age affects that number, is the most useful thing you can do before deciding to move forward.

Get a Personalised Egg Freezing Assessment

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre can give you an honest, individualised picture of your egg freezing options.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

Period pain is so common that it’s often dismissed as just something to push through. But dysmenorrhea (the medical term for painful periods) accounts for an estimated 140 million lost work hours every year in the US alone — it’s a genuine, treatable medical issue, not something to simply endure.

This guide explains the two very different types of dysmenorrhea, current treatment guidelines, and when it’s time to look deeper for an underlying cause.

Primary vs. Secondary Dysmenorrhea: The Key Distinction

Primary Dysmenorrhea

This is period pain without any underlying pelvic pathology. It’s caused by prostaglandins — natural chemicals that trigger uterine contractions during your period. Higher prostaglandin levels mean stronger contractions, and stronger contractions mean more pain.

Primary dysmenorrhea typically has no abnormal findings on physical exam or imaging — the pain is real, but there’s no structural cause behind it.

Secondary Dysmenorrhea

This is period pain caused by an identifiable underlying condition, most commonly:

  • Endometriosis
  • Adenomyosis
  • Uterine fibroids
  • Cervical stenosis (narrowing of the cervical opening)
  • Ovarian cysts

Secondary dysmenorrhea often shows up differently than primary dysmenorrhea — pain that’s progressively worsening over time, starting later in life rather than from your teenage years, or accompanied by other symptoms like heavy bleeding or pain outside of your period.

The Current, Evidence-Based Approach to Treatment

Here’s something genuinely important from current clinical guidelines: you don’t need a confirmed diagnosis before starting treatment. Since both primary and secondary dysmenorrhea generally respond to the same initial treatments, doctors are advised to start symptomatic treatment right away, rather than delaying relief while pursuing extensive testing upfront.

First-Line Treatment: NSAIDs

NSAIDs (like ibuprofen or naproxen) work by reducing prostaglandin production, directly addressing the root cause of the pain. A systematic review of 73 clinical trials confirmed NSAIDs are significantly more effective than placebo for dysmenorrhea pain — notably, this same effectiveness hasn’t been shown for aspirin or plain acetaminophen (paracetamol).

Getting the dosing right matters more than people realise:

  • Start at the very first sign of symptoms or bleeding — don’t wait until pain is already severe
  • Take on a scheduled basis, not just when pain becomes unbearable
  • Continue for the first 1–3 days of your period, or for as long as cramping typically lasts

Underdosing is a common, often overlooked reason NSAIDs seem “not to work” — particularly in younger patients.

First-Line Treatment: Hormonal Options

Hormonal contraceptives are equally considered first-line therapy, and include:

  • Combined oral contraceptive pills
  • The vaginal ring or transdermal patch
  • Hormonal IUDs (LNG-IUD)
  • Contraceptive implants

Current guidelines note that no strong evidence favours NSAIDs over hormonal options, or vice versa — both are considered legitimate first choices, and the right one for you depends on your other needs (like contraception) and personal preference.

Complementary Approaches

Heat therapy, regular exercise, and certain supplements (like ginger) have some supporting evidence, though generally weaker than NSAIDs or hormonal treatment. These are reasonable to use alongside first-line treatment, particularly for those who prefer to minimise medication use.

When Should You Suspect a Secondary Cause?

Current guidelines recommend further evaluation — including a detailed pelvic exam and transvaginal ultrasound — if:

  • Symptoms persist despite 3–6 months of properly optimised NSAID and/or hormonal treatment
  • Pain is progressively worsening rather than staying stable
  • Other symptoms are present, such as heavy bleeding, pain during intercourse, or pelvic pain outside your period
  • Pain started later in life, rather than being present since your teenage years

A thorough physical examination at this stage often includes assessment of the rectovaginal area, pelvic floor muscles, and abdominal wall — details that help guide whether further imaging or even diagnostic laparoscopy is appropriate.

When Is Laparoscopy Considered?

Laparoscopy isn’t a first step — it’s generally reserved for cases where pain persists despite an adequate trial of medical therapy (typically 3–6 months), and there’s a reasonably high suspicion of an underlying condition like endometriosis based on your history and exam findings.

Dysmenorrhea Treatment at Sree Swapna Fertility Centre

As one of the best fertility centers in Hyderabad, we treat period pain as a genuine medical concern deserving proper evaluation — not something to simply prescribe painkillers for indefinitely without asking why it’s happening.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, and is a trained laparoscopic surgeon with over 15 years of experience. Her approach starts with proper first-line treatment, but includes genuine attention to when your symptoms suggest something more — moving to detailed pelvic ultrasound and, when appropriate, laparoscopic evaluation for conditions like endometriosis or adenomyosis.

Both our Kondapur and Attapur clinics offer in-house diagnostic ultrasound, so if your period pain isn’t responding to standard treatment, we can properly investigate rather than simply increasing your painkiller dose indefinitely.

Frequently Asked Questions

1. What is the difference between primary and secondary dysmenorrhea?

Primary dysmenorrhea has no underlying pelvic pathology and is caused by natural prostaglandins, while secondary dysmenorrhea is caused by an identifiable condition like endometriosis, adenomyosis, or fibroids.

2. Do I need a diagnosis before starting period pain treatment?

No, current guidelines recommend starting NSAID and/or hormonal treatment right away, since both primary and secondary dysmenorrhea generally respond to the same initial approach.

3. What is the first-line treatment for painful periods?

NSAIDs and hormonal contraceptives are both considered first-line treatments, with no strong evidence favouring one over the other.

4. Why might NSAIDs not seem to work for my period pain?

Underdosing is a common issue — NSAIDs work best when started at the first sign of symptoms and taken on a scheduled basis, not just when pain becomes severe.

5. Are aspirin and paracetamol as effective as NSAIDs for period pain?

No, research supporting effectiveness for dysmenorrhea specifically applies to NSAIDs like ibuprofen and naproxen, not aspirin or plain paracetamol.

6. When should I suspect a secondary cause for my period pain?

If symptoms persist despite 3–6 months of proper treatment, are progressively worsening, or are accompanied by heavy bleeding or pain outside your period.

7. What conditions commonly cause secondary dysmenorrhea?

Endometriosis, adenomyosis, uterine fibroids, cervical stenosis, and ovarian cysts are among the most common causes.

8. Is a transvaginal ultrasound needed for every case of period pain?

Not necessarily for typical primary dysmenorrhea, but it’s recommended if symptoms persist despite treatment or other concerning features are present.

9. Can hormonal IUDs help with period pain?

Yes, hormonal IUDs are considered an effective first-line option for managing dysmenorrhea.

10. When is laparoscopy considered for period pain?

Generally when pain persists despite 3–6 months of adequate medical treatment and there’s a reasonable suspicion of an underlying condition like endometriosis.

11. Are heat therapy and exercise effective for period pain?

They have some supporting evidence, generally weaker than NSAIDs or hormonal treatment, but are reasonable complementary options.

12. Can period pain that started later in life be a red flag?

Yes, pain that begins later in life, rather than from adolescence, can suggest a secondary cause and may warrant further evaluation.

13. Is dysmenorrhea a common issue?

Yes, it’s extremely common and represents a significant public health and economic burden due to lost work and school days.

14. Can dysmenorrhea affect fertility?

Primary dysmenorrhea itself doesn’t affect fertility, but some secondary causes, like endometriosis or adenomyosis, can.

15. What does a pelvic exam for period pain typically involve?

It may include assessment of the rectovaginal area, pelvic floor muscles, and abdominal wall, alongside a standard gynaecological exam.

16. Can combined oral contraceptive pills help even if I’m not sexually active?

Yes, hormonal contraceptives are used for dysmenorrhea management regardless of sexual activity, based on their hormonal effect on the menstrual cycle.

17. Is it normal for period pain treatment to take a few months to assess properly?

Yes, guidelines generally recommend a 3–6 month trial of optimised treatment before concluding it isn’t working and pursuing further evaluation.

18. Can ginger supplements help with period pain?

Some evidence supports ginger as a complementary option, though it’s generally considered weaker evidence compared to NSAIDs or hormonal treatment.

19. Does dysmenorrhea always require surgery?

No, most cases are effectively managed with NSAIDs and/or hormonal treatment, with surgery reserved for confirmed secondary causes not responding to medical management.

20. Can adolescents be under-treated for period pain?

Yes, underdosing and inconsistent NSAID use is particularly common in adolescents, which can lead to the perception that treatment isn’t working.

21. Should I track my symptoms before seeing a doctor about period pain?

Yes, noting your pain pattern, timing, and any other symptoms can help your doctor determine whether further evaluation is needed.

22. Where can I get dysmenorrhea evaluated and treated in Hyderabad?

Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers comprehensive dysmenorrhea evaluation and treatment at both our Kondapur and Attapur clinics.

Conclusion

Painful periods deserve real treatment, not just quiet endurance. Starting with properly dosed NSAIDs or hormonal options is the right first step for almost everyone — but if your pain persists despite genuine effort with these treatments, it’s a clear signal to look deeper for an underlying cause, rather than simply living with it.

Get Your Period Pain Properly Evaluated

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre can help you find real, lasting relief — whatever’s behind your pain.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

If you’ve been told you’re a “poor ovarian responder” — meaning your ovaries produce fewer eggs than expected during IVF stimulation — time can feel like it’s working against you. Every month spent waiting between cycles is a month your ovarian reserve continues to decline.

DuoStim was developed specifically to address this problem, by fitting two egg retrieval opportunities into the time it would normally take for just one.

What Is DuoStim?

DuoStim (dual or double stimulation) involves performing two ovarian stimulations within the same menstrual cycle — one during the follicular phase (the first half of your cycle), and a second during the luteal phase (shortly after your first egg retrieval, in the same month).

This approach — sometimes also referred to as the “Shanghai protocol,” reflecting its origins — was made possible by an important scientific discovery: follicles don’t only develop and become recruitable during the follicular phase. Multiple “waves” of follicle development can occur within a single ovarian cycle, meaning the luteal phase holds real, usable potential that traditional IVF protocols simply weren’t designed to capture.

Why Was DuoStim Developed for Poor Ovarian Responders?

Poor ovarian response affects roughly 9–24% of women undergoing IVF, and despite various stimulation protocol adjustments over the years, outcomes for this group have historically remained difficult to improve. DuoStim emerged as a genuinely different approach: rather than trying to coax more eggs out of a single stimulation, it captures two separate opportunities within one cycle.

What Does the Research Actually Show?

This is where DuoStim’s evidence becomes genuinely compelling:

  • Luteal phase stimulation often yields more oocytes than the initial follicular phase stimulation in the same patient
  • Egg competence is comparable between the two phases — fertilisation rates, blastocyst formation rates, and euploidy (chromosomally normal) rates were found to be similar in a multicentre study
  • The real impact shows up in cumulative results: in one multicentre study of poor prognosis patients, the proportion of patients obtaining at least one chromosomally normal (euploid) blastocyst rose from 42.3% after follicular phase stimulation alone to 65.5% once luteal phase stimulation was added — a genuinely meaningful increase in a patient population where every additional viable embryo matters

Does DuoStim Guarantee Better Pregnancy Outcomes?

It’s important to be honest here: DuoStim’s clearest advantage is time efficiency — maximising the number of oocytes and embryos obtained within the shortest possible window, which matters enormously for poor responders and for time-sensitive situations like fertility preservation before cancer treatment.

However, at least one study comparing DuoStim to two separate, consecutive mild stimulation cycles (spread across two months) found that while DuoStim produced fewer frozen embryos in older poor-responder patients specifically, pregnancy outcomes were not significantly different between the two approaches. This suggests DuoStim’s core value is compressing your timeline, rather than a guaranteed increase in your overall chance of pregnancy compared to spacing stimulations across separate cycles — though for many patients, that time savings is itself a significant, practical benefit.

Who Might DuoStim Be Recommended For?

  • Women with low AMH or a low antral follicle count, indicating reduced ovarian reserve
  • Poor responders to a previous standard IVF stimulation cycle
  • Women needing urgent fertility preservation, such as before starting cancer treatment, where waiting for a second natural cycle isn’t a realistic option
  • Patients undergoing PGT-A (embryo genetic testing) cycles, where accumulating enough tested, euploid embryos in the shortest time is a priority

What Does the DuoStim Process Involve?

  1. Follicular phase stimulation: Ovarian stimulation medication begins early in your cycle, followed by egg retrieval
  2. Luteal phase stimulation: A second round of stimulation begins shortly after the first retrieval, within the same cycle, followed by a second egg retrieval
  3. Fertilisation and embryo development: Eggs from both retrievals are fertilised (typically via ICSI, given the smaller egg numbers often involved) and cultured
  4. Genetic testing (if applicable): Embryos may undergo PGT-A testing to identify chromosomally normal embryos before transfer
  5. Embryo transfer: Since DuoStim involves back-to-back stimulation, embryo transfer is typically done in a later, separate frozen embryo transfer cycle, once your body has had time to recover

Does Trigger Medication Choice Matter?

Yes — research suggests that using a GnRH agonist or recombinant hCG as the trigger medication, rather than urinary hCG, is associated with better quality embryos at both the follicular and luteal phase stages. This is a detail worth discussing with your specialist as part of your specific protocol.

DuoStim IVF at Sree Swapna Fertility Centre

As one of the best fertility centers in Hyderabad for complex fertility cases, we consider DuoStim specifically for patients where time and egg yield genuinely matter — not as a routine, one-size-fits-all protocol.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, holds an MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, alongside training as a laparoscopic surgeon, with over 15 years of experience in reproductive medicine. Her approach to poor ovarian response and low AMH cases includes a thorough discussion of protocol options — including whether DuoStim, sequential mild stimulation cycles, or another approach best fits your specific timeline and ovarian reserve profile.

Both our Kondapur and Attapur clinics offer the diagnostic evaluation, monitoring, and embryology support needed for DuoStim cycles, including access to PGT-A testing when appropriate.

Frequently Asked Questions

1. What is DuoStim in IVF?

It’s a technique involving two ovarian stimulations and egg retrievals within the same menstrual cycle — one in the follicular phase, one in the luteal phase.

2. Who is DuoStim typically recommended for?

Primarily poor ovarian responders, women with low AMH, and patients needing urgent fertility preservation, such as before cancer treatment.

3. Does the luteal phase actually produce usable eggs?

Yes, research has shown follicles can develop and respond to stimulation during the luteal phase, sometimes yielding more oocytes than the follicular phase in the same patient.

4. Is egg quality different between the two stimulation phases?

Research suggests egg competence — fertilisation, blastocyst formation, and euploidy rates — is generally comparable between follicular and luteal phase stimulation.

5. Does DuoStim guarantee a higher pregnancy rate than doing two separate cycles?

Not necessarily — one study found no significant difference in pregnancy outcomes compared to two consecutive mild stimulation cycles, though DuoStim compresses the timeline significantly.

6. What is the main advantage of DuoStim?

Its main advantage is time efficiency — maximising the number of eggs and embryos obtained within a single month, rather than waiting across multiple cycles.

7. Is DuoStim also called the Shanghai protocol?

Yes, this name reflects its origins, and it’s used somewhat interchangeably with DuoStim in the literature.

8. How common is poor ovarian response in IVF patients?

It’s estimated to affect roughly 9–24% of women undergoing IVF.

9. Does DuoStim increase the chance of getting at least one healthy embryo?

Research from a multicentre study found the rate of obtaining at least one euploid blastocyst rose significantly when luteal phase stimulation was added to follicular phase stimulation.

10. Is ICSI typically used with DuoStim?

Yes, since egg numbers can be limited in poor responders, ICSI is commonly used to maximise fertilisation chances.

11. Does trigger medication choice affect DuoStim outcomes?

Yes, research suggests GnRH agonist or recombinant hCG triggers may yield better quality embryos than urinary hCG in both stimulation phases.

12. Is embryo transfer done immediately after DuoStim retrievals?

Typically no — embryo transfer is usually done in a separate, later frozen embryo transfer cycle, allowing the body time to recover.

13. Can DuoStim be used for fertility preservation before cancer treatment?

Yes, its time-efficient nature makes it particularly useful when starting cancer treatment promptly is a priority.

14. Is DuoStim suitable for women with normal ovarian reserve?

It’s primarily studied and used for poor ovarian responders and time-sensitive cases, rather than routine use in women with normal reserve.

15. How is DuoStim different from a standard IVF cycle?

Standard IVF typically involves one stimulation and retrieval per cycle, while DuoStim performs two within the same cycle.

16. Does age affect how well DuoStim works?

Some research suggests older poor-responder patients may see somewhat different embryo yield patterns compared to younger patients, so individual assessment matters.

17. Is DuoStim more expensive than standard IVF?

It can involve additional monitoring and medication costs due to the two stimulation phases — discuss specific cost implications with your clinic.

18. Can PGT-A testing be combined with DuoStim?

Yes, DuoStim is often used alongside PGT-A to accumulate enough tested, chromosomally normal embryos in the shortest possible time.

19. How soon after the first retrieval does luteal phase stimulation begin?

It typically begins shortly after the first retrieval, within the same menstrual cycle, though exact timing depends on your individual monitoring.

20. Is DuoStim considered an experimental technique?

No, it’s a well-studied approach with a substantial and growing body of clinical research, particularly for poor ovarian responders.

21. Should I ask my specialist if DuoStim is right for me?

Yes, it’s a reasonable question if you’ve been identified as a poor responder or have low AMH — your specialist can assess whether it fits your specific situation.

22. Where can I access DuoStim IVF treatment in Hyderabad?

Sree Swapna Fertility Centre, a leading best fertility center in Hyderabad, offers DuoStim protocols for appropriate candidates at both our Kondapur and Attapur clinics.

Conclusion

DuoStim offers a genuinely valuable option for poor ovarian responders and women with low AMH — not by guaranteeing a higher overall pregnancy rate, but by compressing the time needed to gather eggs and embryos, which matters enormously when ovarian reserve or treatment timing is a pressing concern. The right protocol for you depends on your specific reserve, age, and timeline, and is worth a detailed conversation with your specialist.

Discuss Whether DuoStim Is Right for You

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre can help determine whether DuoStim or another protocol best fits your ovarian reserve and treatment timeline.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

Choosing a fertility specialist is one of the more personal medical decisions you’ll make — you’re not just looking for qualifications on paper, but someone who will guide you through what can be an emotionally demanding journey with genuine skill and care.

Dr. Swapna Naik is the Clinical Director and Chief IVF Consultant at Sree Swapna Fertility Centre, recognised as one of the best fertility centers in Hyderabad, with over 15 years of experience in reproductive medicine and laparoscopic surgery.

Qualifications & Training

Dr. Naik’s training reflects a genuinely comprehensive foundation in both gynaecology and specialised reproductive medicine:

  • MBBS — foundational medical degree
  • DGO (Diploma in Gynaecology & Obstetrics)
  • DRM (Diploma in Reproductive Medicine)
  • DFM (Diploma in Fertility Medicine)
  • Diploma in Reproductive Medicine, Germany — advanced international training in assisted reproduction
  • Fellowship in Advanced ART (Assisted Reproductive Technology)
  • Trained Laparoscopic Surgeon

This combination — international training alongside hands-on surgical qualification — is genuinely uncommon, and it shapes how she approaches patient care: not treating fertility and surgical needs as separate problems requiring separate doctors, but as one connected picture.

Areas of Expertise

Dr. Naik’s practice spans the full range of fertility and reproductive care:

  • IVF (In Vitro Fertilisation) and ICSI (Intracytoplasmic Sperm Injection)
  • IUI (Intrauterine Insemination)
  • Ovulation induction for conditions like PCOS
  • Fertility preservation, including egg and embryo freezing
  • Donor treatments, including donor egg IVF
  • Laparoscopic and hysteroscopic surgery, for conditions like endometriosis, fibroids, and adenomyosis
  • Male factor infertility management, including surgical sperm retrieval (TESA/PESA)
  • PCOD/PCOS management

Her Approach to Patient Care

Fertility treatment involves more than a treatment protocol — it involves real people navigating uncertainty, hope, and sometimes repeated setbacks. Dr. Naik’s approach centres on:

  • Thorough, individualised diagnosis before recommending any treatment path
  • Clear, honest communication about realistic expectations, rather than overpromising outcomes
  • Treating both partners’ fertility factors as equally important, rather than focusing solely on the female partner
  • Combining medical and surgical expertise, so patients aren’t shuffled between multiple specialists for related issues

What Patients Say

Across independent review platforms, patients consistently describe Dr. Naik as attentive, patient in explaining treatment options, and reassuring during what is often an emotionally difficult journey. Many specifically mention feeling genuinely heard during consultations, rather than rushed through appointments — a quality that matters as much as clinical expertise during fertility treatment.

Where to Consult Dr. Swapna Naik

Dr. Naik practices at both Sree Swapna Fertility Centre locations in Hyderabad:

Kondapur (Flagship Centre)

📍 2nd Floor, GT/5, 1-51/192, Masjid Banda Rd, above Ratnadeep Building, Kondapur, Hyderabad – 500084 🗺️ Easily accessible from HITEC City, Gachibowli, Madhapur, Miyapur, and Kukatpally

Attapur

📍 3rd Floor, Naredi Square Building, Pillar No. 181, 304, Attapur, Upperpally, Hyderabad – 500039 🗺️ Easily accessible from Rajendranagar, Mehdipatnam, and Tolichowki

Clinic Timings: Monday – Saturday, 9:00 AM – 7:00 PM | Sunday: By appointment

Why Patients Choose Sree Swapna Fertility Centre

  • A specialist combining fertility medicine and surgical skill, reducing the need for multiple referrals
  • In-house CLIA-certified embryology lab, with vitrification and time-lapse imaging
  • Full diagnostic and surgical facilities on-site, including ultrasound, OT, and andrology lab
  • Two convenient locations across Hyderabad, both led by the same experienced clinical team
  • Personalised treatment plans, built around each patient’s specific diagnosis and goals

Frequently Asked Questions

1. What are Dr. Swapna Naik’s qualifications?

MBBS, DGO, DRM, DFM, a Diploma in Reproductive Medicine from Germany, and a Fellowship in Advanced ART, alongside training as a laparoscopic surgeon.

2. How many years of experience does Dr. Naik have?

Over 15 years of experience in reproductive medicine and laparoscopic surgery.

3. Where does Dr. Swapna Naik practice in Hyderabad?

She consults at both the Kondapur (flagship) and Attapur clinics of Sree Swapna Fertility Centre.

4. Does Dr. Naik treat male infertility as well?

Yes, her practice includes comprehensive male factor infertility management, including surgical sperm retrieval techniques.

5. What is Dr. Naik’s international training background?

She holds a Diploma in Reproductive Medicine from Germany, in addition to her Indian qualifications and fellowship training.

6. Can Dr. Naik perform laparoscopic surgery for endometriosis or fibroids?

Yes, she is a trained laparoscopic surgeon who manages conditions like endometriosis, fibroids, and adenomyosis directly.

7. What treatments does Dr. Naik specialise in?

IVF, ICSI, IUI, ovulation induction, fertility preservation, donor treatments, and laparoscopic/hysteroscopic surgery.

8. Is Dr. Naik available at both Sree Swapna clinics?

Yes, she practices at both the Kondapur and Attapur centres.

9. What are the clinic timings?

Monday to Saturday, 9:00 AM to 7:00 PM, with Sunday consultations available by appointment.

10. How do I book a consultation with Dr. Naik?

You can call, WhatsApp, or book online through the Sree Swapna Fertility Centre website.

11. Does Dr. Naik treat PCOS and PCOD?

Yes, PCOS/PCOD management is part of her comprehensive fertility care offering.

12. Does Sree Swapna Fertility Centre have an in-house embryology lab?

Yes, both clinics are supported by a CLIA-certified embryology lab with vitrification and time-lapse imaging technology.

13. What should I bring to my first consultation with Dr. Naik?

Any previous test reports, semen analysis results, or treatment history, if available — though these aren’t required for a first visit.

14. Can I get a second opinion from Dr. Naik after failed IVF cycles elsewhere?

Yes, reviewing prior treatment history and a fresh diagnostic evaluation is a common and reasonable step.

15. Does Dr. Naik offer donor egg or donor sperm treatments?

Yes, donor treatment programmes, including donor egg IVF, are part of her practice.

16. Is the Kondapur clinic accessible from HITEC City or Gachibowli?

Yes, the Kondapur clinic is easily accessible from HITEC City, Gachibowli, Madhapur, and nearby areas.

17. What makes Dr. Naik’s approach to fertility care different?

Her combination of advanced reproductive medicine training and hands-on surgical qualification allows her to manage both fertility and related surgical needs directly.

18. Are both Sree Swapna clinics equally equipped?

Yes, both the Kondapur and Attapur clinics follow the same clinical standards and diagnostic capabilities under Dr. Naik’s guidance.

19. What is the first step to start treatment with Dr. Naik?

Book a consultation, where your specific case and history will be reviewed before recommending a personalised treatment plan.

20. Does Dr. Naik perform surgical sperm retrieval procedures?

Yes, procedures like TESA and PESA for male factor infertility are part of her practice.

21. How experienced is Dr. Naik with complex fertility cases?

With over 15 years of experience and a track record of guiding thousands of patients through fertility treatment, she has managed a wide range of straightforward and complex cases.

22. Where can I find the best fertility doctor in Hyderabad for a combined medical and surgical approach?

Dr. Swapna Naik at Sree Swapna Fertility Centre offers this combined expertise at both the Kondapur and Attapur clinics.

Conclusion

Choosing a fertility specialist means looking for genuine expertise, honest communication, and a treatment philosophy that puts your specific situation first — not a generic protocol. Dr. Swapna Naik brings comprehensive qualifications, international training, and over 15 years of hands-on experience to every patient she sees at Sree Swapna Fertility Centre, a trusted best fertility center in Hyderabad.

Book a Consultation With Dr. Swapna Naik

Whether you need IVF, laparoscopic surgery, or a comprehensive fertility evaluation, Dr. Swapna Naik and the team at Sree Swapna Fertility Centre are here to guide you with clarity and compassion.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

Being told donor eggs might be the right path forward can feel like a lot to process at once — emotionally and practically. It’s worth knowing upfront: this is a well-established, legally regulated, and often highly effective option, not a last resort.

This guide walks through how donor egg IVF actually works, India’s legal framework around it, what affects cost, and what current research says about success rates.

When Is Donor Egg IVF Recommended?

Donor eggs are typically recommended when:

  • Age-related decline in egg quantity or quality makes conception with your own eggs unlikely to succeed
  • Premature ovarian insufficiency or very low ovarian reserve is present
  • Repeated IVF failures using your own eggs, despite good embryo transfer conditions
  • Genetic conditions that could be passed on through your own eggs
  • Certain medical conditions, such as Turner syndrome, where ovarian function is absent or severely reduced

How Does Donor Egg IVF Actually Work?

  1. Donor selection: A donor is matched from an ICMR-registered ART bank, based on physical characteristics and medical screening — not chosen directly by you, since Indian law requires anonymous donation
  2. Donor screening: Donors undergo thorough medical, genetic, and infectious disease testing (including HIV, hepatitis B and C, and syphilis) before being accepted into an ART bank
  3. Cycle synchronisation: Your uterine lining is prepared with hormonal medication to align with the donor’s egg retrieval and fertilisation timeline
  4. Fertilisation: Donor eggs are fertilised with sperm (your partner’s or donor sperm, depending on your situation) in the lab
  5. Embryo transfer: The resulting embryo is transferred into your uterus
  6. Pregnancy support: Hormonal support continues in early pregnancy to support implantation

You carry the pregnancy and are the legal mother of the child — the egg donor has no legal parental rights under Indian law.

The Legal Framework: India’s ART Act, 2021

Egg donation in India is governed by the Assisted Reproductive Technology (Regulation) Act, 2021, which came into effect in January 2023, along with subsequent ART Rules. Key protections built into this framework include:

  • Mandatory registration: Egg donation must go through an ICMR-registered ART bank — informal or independent arrangements are illegal
  • Anonymity: Neither the recipient nor the donor learns the other’s identity; you receive relevant medical and physical characteristics, but not identifying details
  • Donor eligibility criteria: Donors must fall within a specific age range and undergo thorough health screening
  • Donation limits: Current regulations restrict how often and to how many recipients a single donor can donate, to protect donor health and limit genetic overlap between offspring
  • Mandatory donor insurance: The treating clinic or commissioning couple must provide insurance coverage for the donor, protecting her against health risks related to the donation process
  • Altruistic donation only: Commercial sale of eggs is not permitted; donation must be voluntary, within the compensation framework set by law

Because this legal framework is genuinely detailed, it’s worth directly asking any clinic you’re considering whether their donor eggs are sourced through a registered ART bank — this protects you, the donor, and any child born from the treatment.

What Does Current Research Say About Success Rates?

Donor egg IVF is generally associated with meaningfully higher success rates than IVF using a patient’s own eggs, particularly for women facing age-related decline in egg quality or diminished ovarian reserve. This makes sense biologically: since donors are young and thoroughly screened, embryo quality and chromosomal normality rates tend to be significantly better than with eggs affected by age-related decline.

Reported clinical pregnancy and success rates for donor egg IVF vary across published sources, generally falling in a notably higher range than typical self-cycle IVF success rates for older patients or those with diminished ovarian reserve. It’s worth asking any clinic directly for their own reported live birth rate specifically for donor egg cycles, rather than relying on a single generic industry figure, since individual clinic outcomes can vary based on lab quality, protocol, and patient population.

What Affects the Cost of Donor Egg IVF?

  • Donor matching and screening costs, which form part of the overall ART bank process
  • Your own cycle preparation, including hormonal medication to prepare the uterine lining
  • Fertilisation method used (conventional IVF vs. ICSI, depending on sperm quality)
  • Number of embryo transfer attempts needed
  • Additional testing, such as genetic screening of embryos, if opted for

Reported costs for donor egg IVF in India vary meaningfully depending on the clinic, city, and specific protocol used. For an accurate, personalised estimate, it’s best to discuss your specific situation directly with your treating clinic rather than relying on a generic published range.

Emotional Considerations Worth Acknowledging

Choosing donor eggs is not just a medical decision — many recipients experience complex feelings around genetic connection, and this is a completely normal part of the process. Counselling support, before and during treatment, is strongly recommended, and a good clinic will make space for this conversation rather than rushing past it.

It’s also worth knowing that during pregnancy, your body’s hormonal, physical, and emotional environment plays a genuine role in your baby’s development — the connection you build with your child begins well before birth and isn’t limited to genetics alone.

Donor Egg IVF at Sree Swapna Fertility Centre

As a best fertility center in Hyderabad for comprehensive fertility care, we source donor eggs exclusively through ICMR-registered ART banks, in full compliance with the ART Act, 2021.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, brings over 15 years of experience in reproductive medicine and has guided more than 5,000 successful pregnancies, including patients who conceived through donor egg treatment. Our team provides thorough donor matching support, transparent legal guidance, and counselling support throughout the process — at both our Kondapur and Attapur clinics.

For an accurate, personalised cost estimate and realistic success rate discussion based on your specific medical profile, we recommend a detailed consultation rather than relying on generic published figures.

Frequently Asked Questions

1. When is donor egg IVF recommended?

It’s typically recommended for age-related decline in egg quality, premature ovarian insufficiency, repeated IVF failures with your own eggs, or certain genetic or medical conditions.

2. Is egg donation legal in India?

Yes, it’s legal and regulated under the Assisted Reproductive Technology (Regulation) Act, 2021, and must be conducted through ICMR-registered ART banks.

3. Can I choose my own egg donor directly?

No, Indian law requires anonymous donation through a registered ART bank — you receive relevant medical and physical characteristics, but not the donor’s identity.

4. Who is the legal mother of a child born through donor egg IVF?

You are — the recipient carries the pregnancy and is the legal mother, with the egg donor having no parental rights under Indian law.

5. Are donor eggs in India properly screened?

Yes, donors undergo thorough medical, genetic, and infectious disease screening before being accepted by a registered ART bank.

6. Is donor egg IVF more successful than IVF with my own eggs?

Generally, yes, particularly for women with age-related decline in egg quality or diminished ovarian reserve, since donor eggs come from young, screened donors.

7. How much does donor egg IVF cost in India?

Costs vary depending on the clinic, city, and specific protocol used — it’s best to get a personalised estimate directly from your treating clinic.

8. Does my partner’s sperm get used with donor eggs?

Yes, typically your partner’s sperm is used to fertilise the donor eggs, unless donor sperm is also needed for your specific situation.

9. Is counselling recommended before donor egg IVF?

Yes, given the emotional considerations around genetic connection, counselling support is strongly recommended and should be offered by your clinic.

10. Can a donor donate eggs more than once?

Current regulations place specific limits on donation frequency and the number of recipients per donor, to protect donor health and limit genetic overlap.

11. Is donor egg IVF the same process as regular IVF?

It’s similar, with the key difference being that donor eggs, rather than your own, are fertilised and transferred, requiring cycle synchronisation between donor and recipient.

12. How is the donor matched to me?

Matching is generally based on physical characteristics and medical history, coordinated through the registered ART bank rather than direct selection.

13. Is commercial sale of eggs allowed in India?

No, only altruistic, voluntary donation is permitted under the ART Act, within the legally defined compensation framework.

14. Does the child have any legal right to donor information later in life?

Non-identifying medical and health information may be accessible under specific circumstances defined by law, though full donor identity remains protected.

15. Can international or NRI patients access donor egg IVF in India?

Yes, many clinics in India treat international and NRI patients for donor egg IVF, subject to applicable legal and documentation requirements.

16. Is insurance provided for egg donors in India?

Yes, mandatory insurance coverage for the donor is a legal requirement under the ART Act, 2021.

17. How many embryo transfer attempts are typically needed?

This varies by individual case — some patients conceive on the first transfer, while others may need more than one attempt.

18. Does age of the recipient affect donor egg IVF success?

The donor’s age is generally considered the primary factor for egg quality, though the recipient’s uterine health also plays an important role in implantation success.

19. What tests are done on the recipient before donor egg IVF?

Uterine evaluation, hormonal assessment, and overall health screening are typically part of preparing for donor egg IVF.

20. Can genetic testing be done on embryos from donor eggs?

Yes, genetic screening (PGT) can be added to donor egg IVF cycles if desired, as an additional step.

21. Is donor egg IVF a good option after multiple failed IVF cycles?

It can be, particularly if repeated failures are linked to egg quality issues — this is worth discussing in detail with your specialist based on your specific history.

22. Where can I access donor egg IVF through a registered ART bank in Hyderabad?

Sree Swapna Fertility Centre, recognised as a best fertility center in Hyderabad, sources donor eggs exclusively through ICMR-registered ART banks at both our Kondapur and Attapur clinics.

Conclusion

Donor egg IVF is a well-established, legally protected, and often highly effective path to parenthood — not a fallback option, but a genuinely strong choice for the right clinical situation. Understanding the legal framework, realistic success rates, and what genuinely affects cost can help you approach this decision with clarity rather than uncertainty.

Discuss Donor Egg IVF With Our Team

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre, a trusted best fertility center in Hyderabad, are here to guide you through the process with honesty and care.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Category: Blog

PCOS affects pregnancy in two distinct ways — first, by making it harder to conceive in the first place, and second, by increasing certain risks once pregnancy happens. Understanding both halves of this picture helps you prepare properly, rather than worrying about the wrong thing at the wrong time.

How PCOS Affects Getting Pregnant

The main barrier PCOS creates is irregular or absent ovulation. Without regular ovulation, there’s no egg released each month for sperm to fertilise — which is why irregular periods are often the first clue pointing toward PCOS during a fertility evaluation.

The encouraging part: this is also the most treatable part of PCOS-related infertility.

Ovulation Induction: What’s Changed

For years, clomiphene citrate was the standard first medication used to trigger ovulation in PCOS. That’s changed. Current international guidelines now recommend letrozole as the preferred first-line treatment for PCOS-related anovulatory infertility.

The evidence behind this shift is fairly striking. A major clinical trial found letrozole led to higher ovulation rates (61.7% vs. 48.3%) and higher clinical pregnancy rates (41.9% vs. 28.2%) compared to clomiphene. If you’ve read older information suggesting clomiphene is still the standard, it’s worth knowing this has genuinely moved on.

What About IVF for PCOS?

Here’s something many women with PCOS don’t expect to hear: they often respond very well to IVF stimulation, since PCOS is associated with a higher number of follicles. Some studies show non-obese women with PCOS reaching cumulative IVF live birth rates around 74%, compared to roughly 62% in women without PCOS.

How PCOS Affects Pregnancy Once It Happens

This is the part that deserves equally serious attention. Research consistently shows PCOS is associated with a genuinely higher risk of several pregnancy complications:

  • Miscarriage: Often estimated at around 20–30%, roughly double the risk compared to women without PCOS
  • Gestational diabetes: Occurring in roughly 15–30% of PCOS pregnancies, also about double the typical risk
  • Gestational hypertension and preeclampsia: Consistently shown to occur more frequently in PCOS pregnancies
  • Preterm birth: Also occurring at a somewhat higher rate

This is why PCOS is generally treated as a higher-risk pregnancy category, warranting closer monitoring rather than a “wait and see” approach.

An Important Nuance: PCOS Risk vs. Fertility Treatment Risk

It’s worth separating two different questions: does having PCOS itself increase pregnancy risk, and does treating PCOS infertility with IVF add further risk on top of that? Current guidance suggests assisted reproductive technology itself doesn’t appear to meaningfully add additional miscarriage, preterm birth, or growth restriction risk beyond what’s already associated with the underlying PCOS diagnosis. In other words — the increased risk largely comes from PCOS itself, not from the treatment used to help you conceive.

Does Metformin Prevent These Complications?

This is a common assumption worth correcting. Despite metformin’s popularity in PCOS management, current evidence has not shown it prevents gestational diabetes, late miscarriage, hypertension, preeclampsia, or larger-than-average babies in pregnant women with PCOS. It may still have a role in specific situations, but it isn’t a guaranteed shield against these pregnancy complications, and shouldn’t be relied on as one.

What Can Genuinely Help Reduce These Risks?

  • Preconception weight management, where relevant, since higher BMI is independently linked to greater complication risk
  • Early and repeated screening for gestational diabetes, often starting at the first prenatal visit rather than waiting for the standard mid-pregnancy window
  • Closer blood pressure monitoring throughout pregnancy
  • Regular fetal growth monitoring
  • A coordinated care plan between your fertility specialist and obstetric team, rather than treating these as separate, disconnected phases of your journey

The Reassuring Bottom Line

Having PCOS doesn’t mean complications are inevitable — it means your pregnancy benefits genuinely from closer attention and proactive screening. Many women with PCOS go on to have healthy pregnancies and healthy babies, particularly when risks are anticipated and monitored rather than discovered late.

PCOS Pregnancy Care at Sree Swapna Fertility Centre

As one of the best fertility center in Hyderabad for comprehensive PCOS management, we approach PCOS as a condition requiring attention both before and during pregnancy — not just at the point of conception.

Dr. Swapna Naik, Clinical Director at Sree Swapna Fertility Centre, brings over 15 years of experience in reproductive medicine and has guided more than 5,000 successful pregnancies, including many women with PCOS. Our approach includes evidence-based ovulation induction using letrozole where appropriate, IVF planning tailored to PCOS-specific response patterns, and close coordination around pregnancy monitoring for gestational diabetes and hypertension risk.

Both our Kondapur and Attapur clinics offer in-house diagnostic and monitoring facilities, so your PCOS-related fertility treatment and pregnancy risk management stay properly coordinated under one experienced team.

Frequently Asked Questions

1. Does PCOS affect my chances of getting pregnant?

Yes, PCOS commonly causes irregular or absent ovulation, which is the main reason it affects fertility, though it’s often effectively treatable.

2. Is clomiphene still the first choice for PCOS ovulation induction?

No, current guidelines now recommend letrozole as the preferred first-line treatment, since research shows better ovulation and pregnancy rates compared to clomiphene.

3. Does PCOS increase miscarriage risk?

Yes, research suggests roughly double the miscarriage risk compared to women without PCOS, often estimated around 20–30%.

4. Does PCOS increase the risk of gestational diabetes?

Yes, gestational diabetes occurs in roughly 15–30% of PCOS pregnancies, about twice the typical risk.

5. Is preeclampsia more common in PCOS pregnancies?

Yes, research consistently shows a higher rate of preeclampsia and gestational hypertension in women with PCOS.

6. Does IVF add extra risk on top of PCOS itself?

Current guidance suggests assisted reproductive technology doesn’t meaningfully add additional risk beyond what’s already associated with the underlying PCOS diagnosis.

7. Does metformin prevent gestational diabetes in PCOS pregnancies?

No, current evidence hasn’t shown metformin prevents gestational diabetes or other major PCOS-related pregnancy complications.

8. Do women with PCOS respond well to IVF?

Yes, many women with PCOS respond strongly to IVF stimulation due to a higher number of follicles, with some studies showing notably high cumulative live birth rates.

9. Is PCOS considered a high-risk pregnancy?

Yes, PCOS pregnancies are generally treated as higher-risk, warranting closer monitoring for gestational diabetes, hypertension, and preterm birth.

10. Can weight management before pregnancy reduce PCOS-related risks?

Yes, preconception weight management, where relevant, is associated with reduced complication risk in PCOS pregnancies.

11. Does PCOS increase the risk of a larger-than-average baby?

Evidence on this is mixed, with some research not showing an increased risk over the general population once other factors are accounted for.

12. When should gestational diabetes screening start for women with PCOS?

Many providers recommend screening at the first prenatal visit, in addition to the standard later screening window.

13. Does PCOS increase preterm birth risk?

Yes, research shows a somewhat higher rate of preterm birth in PCOS pregnancies compared to the general population.

14. Can healthy PCOS pregnancies happen without complications?

Yes, many women with PCOS have healthy pregnancies, especially with proactive monitoring and management from early on.

15. Is letrozole safe to use for ovulation induction?

Current large trials and meta-analyses haven’t shown an increase in congenital anomalies or adverse outcomes with letrozole-induced pregnancies.

16. Should I see a specialist before trying to conceive if I have PCOS?

Yes, a preconception consultation can help address weight, ovulation induction options, and risk factors before you start trying.

17. Does PCOS affect pregnancy differently depending on severity?

Yes, factors like BMI, insulin resistance, and specific PCOS phenotype can all influence individual risk levels.

18. Can PCOS-related pregnancy risks be caught early with proper monitoring?

Yes, early and regular screening significantly improves the chances of catching and managing complications before they become serious.

19. Does having PCOS mean I’ll definitely need IVF to conceive?

No, many women with PCOS conceive with lifestyle changes and ovulation induction medication alone, without needing IVF.

20. Is blood pressure monitoring more important in PCOS pregnancies?

Yes, given the higher risk of gestational hypertension and preeclampsia, closer blood pressure monitoring is generally recommended throughout pregnancy.

21. Can PCOS affect pregnancy even if my periods are somewhat regular?

Yes, PCOS-related pregnancy risks like gestational diabetes and hypertension can still apply even with relatively regular cycles, since these relate to underlying metabolic factors.

22. Where can I find the best fertility center in Hyderabad for PCOS pregnancy planning?

Sree Swapna Fertility Centre offers comprehensive PCOS fertility and pregnancy risk management at both our Kondapur and Attapur clinics.

Conclusion

PCOS genuinely affects both your chances of conceiving and your pregnancy once it happens — but neither part of this story needs to be alarming. With current, evidence-based treatment for ovulation induction, and proactive monitoring for pregnancy-specific risks, many women with PCOS go on to have healthy pregnancies and healthy babies.

Plan Your PCOS Pregnancy Journey With Us

Dr. Swapna Naik and the team at Sree Swapna Fertility Centre — recognised as a leading, best fertility center in Hyderabad — are here to guide you through both conception and a well-monitored pregnancy.

📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us

Scroll to Top

To Book an Appointment

+917670804424 📞 Call Now

Recent Posts

Link Between Endometriosis & Recurrent Miscarriage
Jul 27, 2026
Endometrial Receptivity Analysis (ERA): What It Is, How It Works & Who Needs It
Jul 27, 2026
Endometrial Cancer Treatment in Hyderabad | Uterine Cancer Care
Jul 27, 2026
Elagolix for Endometriosis Treatment in Hyderabad
Jul 27, 2026
Egg Freezing Treatment in Hyderabad | Cost & Procedure
Jul 27, 2026
Dysmenorrhea Treatment Doctors in Hyderabad
Jul 27, 2026